Raffaella Ravinetto

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 29

Top Venues

BMJ global health

Journal of pharmaceutical policy and practice

BMC medical ethics

Global bioethics = Problemi di bioetica

Institute Tropical Medicine

KU Leuven (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute Tropical Medicine Nov 01 2006

Belgium

Senior researcher :: Public Health

Education History

KU Leuven

Belgium

PHD :: Biomedical Sciences

Publications

Gwen Lemey, Ynke Larivière, Bernard Isekah Osang'ir, Trésor Zola, Primo Kimbulu, Solange Milolo, Engbu Danoff, Yves Tchuma, Vivi Maketa, Patrick Mitashi, Raffaella Ravinetto, Pierre Van Damme, Jean-Pierre Van Geertruyden, Hypolite Muhindo-Mavoko
An ancillary care policy in a vaccine trial conducted in a resource-constrained setting: evaluation and policy recommendations. BMJ global health 9 (6) (2024)
Gwen Lemey, Ynke Larivière, Bernard Isekah Osang'ir, Trésor Zola, Primo Kimbulu, Solange Milolo, Engbu Danoff, Yves Tchuma, Vivi Maketa, Patrick Mitashi, Raffaella Ravinetto, Pierre Van Damme, Jean-Pierre Van Geertruyden, Hypolite Muhindo-Mavoko
An ancillary care policy in a vaccine trial conducted in a resource-constrained setting: evaluation and policy recommendations. BMJ global health 9 (6) (2024)
Raffaella Ravinetto, Rodrigo Henriquez, Prashanth Nuggehalli Srinivas, Hazel Bradley, Renier Coetzee, Theresa J Ochoa, Jean Claude Semuto Ngabonziza, Jean-Baptiste Mazarati, Kevin K Ariën, Remco van de Pas, Nico Vandaele, Els Torreele
Shaping the future of global access to safe, effective, appropriate and quality health products. BMJ global health 9 (1) (2024)
Raffaella Ravinetto, Rodrigo Henriquez, Prashanth Nuggehalli Srinivas, Hazel Bradley, Renier Coetzee, Theresa J Ochoa, Jean Claude Semuto Ngabonziza, Jean-Baptiste Mazarati, Kevin K Ariën, Remco van de Pas, Nico Vandaele, Els Torreele
Shaping the future of global access to safe, effective, appropriate and quality health products. BMJ global health 9 (1) (2024)
Raffaella Ravinetto, Rodrigo Henriquez, Prashanth Nuggehalli Srinivas, Hazel Bradley, Renier Coetzee, Theresa J Ochoa, Jean Claude Semuto Ngabonziza, Jean-Baptiste Mazarati, Kevin K Ariën, Remco van de Pas, Nico Vandaele, Els Torreele
Shaping the future of global access to safe, effective, appropriate and quality health products. BMJ global health 9 (1) (2024)
Raffaella Ravinetto, Rodrigo Henriquez, Prashanth Nuggehalli Srinivas, Hazel Bradley, Renier Coetzee, Theresa J Ochoa, Jean Claude Semuto Ngabonziza, Jean-Baptiste Mazarati, Kevin K Ariën, Remco van de Pas, Nico Vandaele, Els Torreele
Shaping the future of global access to safe, effective, appropriate and quality health products. BMJ global health 9 (1) (2024)
Gwen Lemey, Ynke Larivière, Bernard Isekah Osang'ir, Trésor Zola, Primo Kimbulu, Solange Milolo, Engbu Danoff, Yves Tchuma, Vivi Maketa, Patrick Mitashi, Raffaella Ravinetto, Pierre Van Damme, Jean-Pierre Van Geertruyden, Hypolite Muhindo-Mavoko
An ancillary care policy in a vaccine trial conducted in a resource-constrained setting: evaluation and policy recommendations. BMJ global health 9 (6) (2024)
Gwen Lemey, Ynke Larivière, Bernard Isekah Osang'ir, Trésor Zola, Primo Kimbulu, Solange Milolo, Engbu Danoff, Yves Tchuma, Vivi Maketa, Patrick Mitashi, Raffaella Ravinetto, Pierre Van Damme, Jean-Pierre Van Geertruyden, Hypolite Muhindo-Mavoko
An ancillary care policy in a vaccine trial conducted in a resource-constrained setting: evaluation and policy recommendations. BMJ global health 9 (6) (2024)
Raffaella Ravinetto, Rodrigo Henriquez, Prashanth Nuggehalli Srinivas, Hazel Bradley, Renier Coetzee, Theresa J Ochoa, Jean Claude Semuto Ngabonziza, Jean-Baptiste Mazarati, Kevin K Ariën, Remco van de Pas, Nico Vandaele, Els Torreele
Shaping the future of global access to safe, effective, appropriate and quality health products. BMJ global health 9 (1) (2024)
Cécile Macé, Jean-Baptiste Nikiema, Omar Serigne Sarr, Patient Ciza Hamuli, Roland Djang'eing'a Marini, Richard Cizungu Neci, Pernette Bourdillon Esteve, Raffaella Ravinetto
The response to substandard and falsified medical products in francophone sub-Saharan African countries: weaknesses and opportunities. Journal of pharmaceutical policy and practice 16 (1) (2023)
Patricia Kingori, Koen Peeters Grietens, Seye Abimbola, Raffaella Ravinetto
Uncertainties about the quality of medical products globally: lessons from multidisciplinary research. BMJ global health 6 (Suppl 3) (2023)
Cécile Macé, Lembit Rägo, Raffaella Ravinetto
How the concept of WHO-listed authorities will change international procurement policies for medicines. BMJ global health 6 (Suppl 3) (2022)
Jacques Zandibeni, Xavier de Béthune, Jean Debethel Bitumba, Jocelyn Mantempa, Léon Tshilolo, Jackie Ndona, Alain Kabemba Mbaya, Donatien Kabamb Kabey, Anselme Mubeneshayi Kananga, Raffaella Ravinetto
Access to opioid analgesics for medical use at hospital level in the Democratic Republic of Congo: an exploratory mixed-method study. Tropical medicine & international health : TM & IH (2022)
Saleh Aljadeeah, Joris Michielsen, Raffaella Ravinetto, Sally Hargreaves, Veronika J Wirtz, Oliver Razum, Federico Gobbi, Karina Kielmann
Facilitating access to medicines and continuity of care for Ukrainian refugees: exceptional response or the promise of more inclusive healthcare for all migrants? BMJ global health 7 (8) (2022)
Raffaella Ravinetto, Jerome Amir Singh
Responsible dissemination of health and medical research: some guidance points. BMJ evidence-based medicine 28 (3) (2022)
Raffaella Ravinetto, Céline Caillet, Muhammad H Zaman, Jerome Amir Singh, Philippe J Guerin, Aasim Ahmad, Carlos E Durán, Amar Jesani, Ana Palmero, Laura Merson, Peter W Horby, E Bottieau, Tammy Hoffmann, Paul N Newton
Preprints in times of COVID19: the time is ripe for agreeing on terminology and good practices. BMC medical ethics 22 (1) (2021)
Ariadna Nebot Giralt, Anthony Bourasseau, Gareth White, Corinne Pouget, Patricia Tabernero, Kerlijn Van Assche, Raffaella Ravinetto
Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward. BMJ global health 5 (10) (2021)
Remco Van De Pas, Marc-Alain Widdowson, Raffaella Ravinetto, Prashanth Nuggehalli Srinivas, Theresa J Ochoa, Thierno Oumar Fofana, Wim Van Damme
COVID-19 vaccine equity: a health systems and policy perspective. Expert review of vaccines (2021)
Serena Frau, Anselme Mubeneshayi Kananga, Jackie Ndona Kingolo, Ghislaine Mbelu Kanyunyu, André Katele H Zongwe, Aaron Nshindi Tshilengi, Raffaella Ravinetto
Training on adequate use of opioid analgesics in West and Central Africa: a neglected step on the way to access to essential medicines? Journal of pharmaceutical policy and practice 14 (1) (2021)
Patrick Soentjens, Nicole Berens-Riha, Yven Van Herrewege, Pierre Van Damme, Emmanuel Bottieau, Raffaella Ravinetto
Vaccinating children in high-endemic rabies regions: what are we waiting for? BMJ global health 6 (2) (2021)
Anthony Bourasseau, Laurine Lavergne, Raffaella Ravinetto
Assessments of the quality systems of pharmaceutical distributors: a remote approach to be applied in times of COVID-19 and beyond. Journal of pharmaceutical policy and practice 14 (1) (2021)
Christophe Perrin, Sandrine Cloez, Catherine Dujardin, Raffaella Ravinetto
Europe should lead in coordinated procurement of quality-assured medicines for programmes in low-income and middle-income countries. BMJ global health 5 (7) (2021)
Gwen Lemey, Ynke Larivière, Trésor Matuvanga Zola, Vivi Maketa, Junior Rika Matangila, Patrick Mitashi, Peter Vermeiren, Séverine Thys, Jessie De Bie, Hypolite Mavoko Muhindo, Raffaella Ravinetto, Pierre van Damme, Jean-Pierre Van Geertruyden
Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo. BMJ global health 6 (6) (2021)
Gamal Khalafalla Mohamed Ali, Raffaella Ravinetto, Abubakr Abdelraouf Alfadl
The importance of visual inspection in national quality assurance systems for medicines. Journal of pharmaceutical policy and practice 13 (2020)
Abha Saxena, Peter Horby, John Amuasi, Nic Aagaard, Johannes Köhler, Ehsan Shamsi Gooshki, Emmanuelle Denis, Andreas A Reis, null null, Raffaella Ravinetto
Ethics preparedness: facilitating ethics review during outbreaks - recommendations from an expert panel. BMC medical ethics 20 (1) (2019)
Patricia Kingori, Koen Peeters Grietens, Seye Abimbola, Raffaella Ravinetto
Poor-quality medical products: social and ethical issues in accessing 'quality' in global health. BMJ global health 4 (6) (2019)
Raffaella Ravinetto, Tim Roosen, Catherine Dujardin
The Belgian commitment to pharmaceutical quality: a model policy to improve quality assurance of medicines available through humanitarian and development programs. Journal of pharmaceutical policy and practice 11 (2018)
Raffaella Ravinetto, Wim Pinxten, Lembit Rägo
Quality of medicines in resource-limited settings: need for ethical guidance. Global bioethics = Problemi di bioetica 29 (1) (2018)
Cari Stek, Charlotte Schutz, Lisette Blumenthal, Friedrich Thienemann, Jozefien Buyze, Christiana Nöstlinger, Raffaella Ravinetto, Edwin Wouters, Robert Colebunders, Gary Maartens, Robert John Wilkinson, Lutgarde Lynen, Graeme Meintjes
Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial). JMIR research protocols 5 (3) (2016)

Raffaella Ravinetto.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Raffaella Ravinetto